Healthcare provider profile · identity verified

Mar Jaminal, M.D.

Family Practice · JACKSONVILLE, FL · NPI 1457411100

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	480	151
Atorvastatin Calcium	Atorvastatin Calcium	466	162
Lisinopril	Lisinopril	336	114
Gabapentin	Gabapentin	309	92
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	262	63
Losartan Potassium	Losartan Potassium	234	77
Hydrochlorothiazide	Hydrochlorothiazide	219	76
Famotidine	Famotidine	211	64
Metformin Hcl	Metformin Hcl	202	67
Albuterol Sulfate Hfa	Albuterol Sulfate	197	44
Carvedilol	Carvedilol	186	61
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	182	34
Metoprolol Succinate	Metoprolol Succinate	177	67
Trulicity	Dulaglutide	153	22
Levothyroxine Sodium	Levothyroxine Sodium	151	44
Fluticasone Propionate	Fluticasone Propionate	146	43
Ozempic	Semaglutide	142	22
Furosemide	Furosemide	139	46
Baclofen	Baclofen	135	44
Pravastatin Sodium	Pravastatin Sodium	116	37
Omeprazole	Omeprazole	110	37
Rosuvastatin Calcium	Rosuvastatin Calcium	102	35
Hydralazine Hcl	Hydralazine Hcl	101	30
Ibuprofen	Ibuprofen	99	38
Oxycodone Hcl	Oxycodone Hcl	97	16
Glipizide	Glipizide	96	33
Trazodone Hcl	Trazodone Hcl	96	25
Potassium Chloride	Potassium Chloride	92	24
Pantoprazole Sodium	Pantoprazole Sodium	88	31
Azithromycin	Azithromycin	85	58
Buspirone Hcl	Buspirone Hcl	85	20
Amoxicillin	Amoxicillin	79	45
Metoprolol Tartrate	Metoprolol Tartrate	75	27
Montelukast Sodium	Montelukast Sodium	73	22
Eliquis	Apixaban	71	24
Tramadol Hcl	Tramadol Hcl	71	17
Jardiance	Empagliflozin	70	21
Ventolin Hfa	Albuterol Sulfate	69	27
Januvia	Sitagliptin Phosphate	68	22
Nifedipine Er	Nifedipine	68	18
Tamsulosin Hcl	Tamsulosin Hcl	67	25
Clotrimazole	Clotrimazole	64	28
Clopidogrel	Clopidogrel Bisulfate	62	19
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	62	18
Tizanidine Hcl	Tizanidine Hcl	59	19
Glipizide Er	Glipizide	54	16
Prednisone	Prednisone	54	16
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	49	13
Fluconazole	Fluconazole	47	16
Spironolactone	Spironolactone	47	16
Ezetimibe	Ezetimibe	45	13
Pregabalin	Pregabalin	45	suppressed
Metformin Hcl Er	Metformin Hcl	41	16
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	39	suppressed
Ondansetron Odt	Ondansetron	37	15
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	36	11
Celecoxib	Celecoxib	36	suppressed
Sertraline Hcl	Sertraline Hcl	36	11
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	35	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	35	11
Symbicort	Budesonide/Formoterol Fumarate	35	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	34	13
Quetiapine Fumarate	Quetiapine Fumarate	34	suppressed
Terazosin Hcl	Terazosin Hcl	34	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	33	suppressed
Topiramate	Topiramate	32	11
Alendronate Sodium	Alendronate Sodium	31	13
Finasteride	Finasteride	31	suppressed
Ondansetron Hcl	Ondansetron Hcl	31	13
Allopurinol	Allopurinol	30	12
Farxiga	Dapagliflozin Propanediol	30	suppressed
Acyclovir	Acyclovir	28	suppressed
Meloxicam	Meloxicam	28	11
Oxycontin	Oxycodone Hcl	28	suppressed
Duloxetine Hcl	Duloxetine Hcl	26	11
Meclizine Hcl	Meclizine Hcl	26	suppressed
Atenolol	Atenolol	25	suppressed
Cephalexin	Cephalexin	25	13
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	25	18
Entresto	Sacubitril/Valsartan	24	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	24	suppressed
Lidocaine	Lidocaine	24	suppressed
Naproxen	Naproxen	24	11
Zolpidem Tartrate	Zolpidem Tartrate	24	suppressed
Glimepiride	Glimepiride	23	suppressed
Hydrocortisone	Hydrocortisone	23	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	22	suppressed
Xarelto	Rivaroxaban	22	suppressed
Methimazole	Methimazole	21	suppressed
Warfarin Sodium	Warfarin Sodium	21	suppressed
Promethazine Hcl	Promethazine Hcl	20	suppressed
Bumetanide	Bumetanide	19	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	19	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	18	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	17	suppressed
Azelastine Hcl	Azelastine Hcl	17	suppressed
Diclofenac Sodium	Diclofenac Sodium	17	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	17	suppressed
Levalbuterol Tartrate Hfa	Levalbuterol Tartrate	17	suppressed
Lorazepam	Lorazepam	17	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	17	suppressed
Clonidine Hcl	Clonidine Hcl	16	suppressed
Donepezil Hcl	Donepezil Hcl	16	suppressed
Lactulose	Lactulose	16	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	16	suppressed
Citalopram Hbr	Citalopram Hydrobromide	15	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	15	suppressed
Loperamide	Loperamide Hcl	15	suppressed
Solifenacin Succinate	Solifenacin Succinate	15	suppressed
Ultra-Fine Micro Pen Needle	Pen Needle, Diabetic	15	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	14	suppressed
Fenofibrate	Fenofibrate	14	suppressed
Mirtazapine	Mirtazapine	14	suppressed
Tresiba Flextouch U-200	Insulin Degludec	14	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	13	suppressed
Methocarbamol	Methocarbamol	13	suppressed
Nystatin	Nystatin	13	suppressed
Torsemide	Torsemide	13	suppressed
Insulin Syringe	Syringe And Needle,insulin,1ml	12	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	12	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	12	suppressed
Paroxetine Hcl	Paroxetine Hcl	12	suppressed
Penicillin V Potassium	Penicillin V Potassium	12	suppressed
Xtampza Er	Oxycodone Myristate	12	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	11	suppressed
Chlorthalidone	Chlorthalidone	11	suppressed
Colesevelam Hcl	Colesevelam Hcl	11	suppressed
Fiasp Flextouch	Insulin Aspart (Niacinamide)	11	suppressed
Incruse Ellipta	Umeclidinium Bromide	11	suppressed
Morphine Sulfate Er	Morphine Sulfate	11	suppressed
Mupirocin	Mupirocin	11	suppressed
Nitroglycerin	Nitroglycerin	11	suppressed
Novolin 70-30 Flexpen	Insulin Nph Hum/Reg Insulin Hm	11	suppressed
Novolog Flexpen	Insulin Aspart	11	suppressed
Prochlorperazine Maleate	Prochlorperazine Maleate	11	suppressed
Ramipril	Ramipril	11	suppressed
Spiriva Handihaler	Tiotropium Bromide	11	suppressed
Verapamil Er	Verapamil Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error